English
-
New & Featured
-
-
Dengue without warning signs: Outpatient management in the public and private setting
ADS22 minutes -
Mass Vaccination During the 2024 Dengue Outbreak in Brazil
ADS27 minutes -
Dengue Immunity: Lessons from clinical trials
ADS17 minutes -
Clinical Management of Dengue with Warning Signs
ADS23 minutes -
The Current Dengue Therapeutics Guideline and How to Deliver Effective Treatment
ADS12 minutes -
Best Practice in Dengue in patient management
ADS18 minutes -
Ideal Dengue Vaccine Characteristics
Medscape -
Dengue Immunization: Special Populations
Medscape -
Dengue: Vaccinating Travelers to Endemic Regions
Medscape -
Dengue Prevention: Integrating Vaccination Into Comprehensive Control Strategies Across Populations
Medscape -
Integrated Dengue Management
Takeda2 minutes -
Climate Change and Dengue
Takeda1 minutes -
Risk Factors for Severe Dengue
Takeda2 minutes -
Global Epidemiology 2025
Takeda3 minutes
Dengue Academy is intended for an international audience of healthcare professionals outside of the US and UK.
This website has been initiated and developed by Takeda
This website is intended for informational purposes only and is not a substitute for healthcare professional’s clinical knowledge or professional judgment.
© Copyright 2025 Takeda Pharmaceutical Company Limited. All rights reserved.
Takeda and the Takeda Logo are registered trademarks of Takeda Pharmaceutical Company Limited.
VV-MEDMAT-55340, Date of preparation: November 2023
Malaysia